GlaxoSmithKline is not owned by a single private entity; rather, it operates as a publicly traded multinational pharmaceutical enterprise with its common shares listed on the London Stock Exchange and American Depositary Shares traded on the New York Stock Exchange. Its massive equity ownership is widely distributed among thousands of institutional asset management firms, global mutual funds, pension funds, and individual retail investors worldwide.